Spesolimab Response in a Patient With Steroid-Resistant Sweet Syndrome
This case report describes a patient with Sweet syndrome whose condition improved with spesolimab after failure of high-dose corticosteroids.
This case report describes a patient with Sweet syndrome whose condition improved with spesolimab after failure of high-dose corticosteroids.
Sponsored by Novartis Pharmaceuticals Corporation Sponsored by Novartis, this video series provides perspective on best practices for the assessment, diagnosis, and treatment of chronic spontaneous…
Disease severity improved from severe to mild after just 6 weeks of twice daily dosage.
This survey study estimates the prevalences and effectiveness associated with different smoking cessation aids in England.
This comparative effectiveness research assesses differences in the association of systemic postnatal corticosteroids with survival free of cerebral palsy by risk of bronchopulmonary dysplasia.
Cemiplimab demonstrated a 68% reduction in recurrence risk for high-risk CSCC in the phase 3 C-POST trial, according to Regeneron’s latest findings.
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
This quality improvement study assesses patient adherence to temperature guidelines for home storage of anti–vascular endothelial growth factor (anti-VEGF) agents in France.
This cohort study assesses changes in overall health, health care utilization, and costs for patients gaining Medicare coverage before and after Medicaid expansion and availability…
This observational study reports on a comprehensive nationwide evaluation of rising gastroenteropancreatic neuroendocrine tumor incidence in the US from 2001 to 2020.
This case-control study compares functional magnetic resonance imaging data from individuals with opioid use disorder (OUD) and healthy control participants to examine whether individuals with…